Chairman and Chief Executive Officer
Marc de Garidel has been Chairman and Chief Executive Officer of the Company since November 2010. Marc de Garidel, 52, graduated from the Ecole Spéciale des Travaux Publics(Frances leading Civil Engineering School) and obtained a business degree at Thunderbird School of Global Management (Arizona, USA).
He started his career in 1983 with the Eli Lilly pharmaceutical group. He held various roles, mainly finance related, firstly in France, then in the United States and finally in Germany. In 1995, he joined Amgen, the American biotech Group, as Vice President, Finance and Treasury for Europe. In 1998, he was appointed at Amgens headquarters in California as Vice President, Corporate Controller and Chief Accounting Officer.
In 2000, Marc de Garidel was offered the role of Vice President, General Manager for France, in charge of general management of Amgen France. In 2006, he was appointed Vice President, Southwestern Europe (France, Spain, Belgium, and Portugal). In 2007, Marc de Garidels responsibilities were expanded to the entire Southern region. This region includes Southern European markets as well as emerging markets such as MEA and Latin America. With this position, Marc de Garidel heads the largest region within Amgen International, with sales of more than $1.5bn.